The PI3K-AKT pathway - a therapeutic target in melanoma brain metastases?

被引：0

作者：

Niessner, H. ^{[1
]}

Schmitz, J. ^{[2
]}

Schmid, A. ^{[2
]}

Sinnberg, T. ^{[1
]}

Tabatabai, G. ^{[3
]}

Weide, B. ^{[1
]}

Garbe, C. ^{[1
]}

Quintanilla-Fend, L. ^{[4
]}

Mai, M. ^{[5
]}

Beissert, S. ^{[5
]}

Kulms, D. ^{[5
]}

Schackert, G. ^{[6
]}

Muders, M. ^{[7
]}

Meinhardt, M. ^{[7
]}

Baretton, G. ^{[7
]}

Pichler, B. ^{[2
]}

Westphal, D. ^{[5
]}

Meier, F. ^{[1
,5
]}

机构：

[1] Univ Tubingen, Dept Dermatol, D-72076 Tubingen, Germany

[2] Univ Tubingen, Dept Preclin Imaging & Radiopharm, D-72076 Tubingen, Germany

[3] Univ Tubingen, Dept Neurol, D-72076 Tubingen, Germany

[4] Univ Tubingen, Dept Pathol, D-72076 Tubingen, Germany

[5] Tech Univ Dresden, Dept Dermatol, Carl Gustav Carus Med Ctr, Dresden, Germany

[6] Tech Univ Dresden, Dept Neurosurg, Carl Gustav Carus Med Ctr, Dresden, Germany

[7] Tech Univ Dresden, Dept Pathol, Carl Gustav Carus Med Ctr, Dresden, Germany

来源：

EXPERIMENTAL DERMATOLOGY | 2016年 / 25卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P209

引用

页码：E35 / E35

页数：1

共 50 条

[1] The Role of the PI3K-AKT Pathway in Melanoma
Davies, Michael A.
CANCER JOURNAL, 2012, 18 (02): : 142 - 147
[2] The PI3K-AKT pathway: A plausible therapeutic target in Parkinson's disease
Goyal, Ahsas
Agrawal, Anant
Verma, Aanchal
Dubey, Nandini
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2022, 129
[3] The multi-faceted roles of the PI3K-AKT pathway in melanoma
Michael A Davies
Journal of Translational Medicine, 13 (Suppl 1)
[4] The PI3K/Akt/mTOR pathway as a preventive target in melanoma brain metastasis
Tehranian, Cedric
Fankhauser, Laura
Harter, Patrick N.
Ratcliffe, Colin D. H.
Zeiner, Pia S.
Messmer, Julia M.
Hoffmann, Dirk C.
Frey, Katharina
Westphal, Dana
Ronellenfitsch, Michael W.
Sahai, Erik
Wick, Wolfgang
Karreman, Matthia A.
Winkler, Frank
NEURO-ONCOLOGY, 2022, 24 (02) : 213 - 225
[5] FUNCTIONAL STUDIES AND POTENTIAL THERAPEUTIC APPROACHES IN DISORDERS OF THE PI3K-AKT PATHWAY
Boccuto, Luigi
Cascio, Lauren
Dyment, David
Jones, Kelly
Norris, Joy
Chen, Chin-Fu
Skinner, Cindy
Basel-Vanagaite, Lina
Stevenson, Roger
Innes, Micheil
Schwartz, Charles
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2015, 167 (08) : 1725 - 1726
[6] Inhibition of the PI3K-AKT signalling pathway to overcome therapy resistance in melanoma-derived brain metastasis
Niessner, H.
Adam, A.
Bornemann, A.
Honegger, J. B.
Hoek, K.
Quintanilla-Fend, L.
Meier, F.
EXPERIMENTAL DERMATOLOGY, 2011, 20 (02) : 194 - 194
[7] Methylation among members of the PI3K/AKT/mTOR pathway in melanoma brain and extracerebral metastases
Meier, Friedegund Elke
Westphal, Dana
Meinhardt, Matthias
Gruetzmann, Konrad
Schrimpf, Daniel
Aust, Daniela Ellen
Schroeck, Evelin
Baretton, Gustavo Bruno
Beissert, Stefan
Schackert, Gabriele
von Deimling, Andreas
Koelsche, Christian
Klink, Barbara
Muders, Michael
Seifert, Michael
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[8] Molecular Profiling of Patient-Matched Brain and Extracranial Melanoma Metastases Implicates the PI3K Pathway as a Therapeutic Target
Chen, Guo
Chakravarti, Nitin
Aardalen, Kimberly
Lazar, Alexander J.
Tetzlaff, Michael T.
Wubbenhorst, Bradley
Kim, Sang-Bae
Kopetz, Scott
Ledoux, Alicia A.
Gopal, Y. N. Vashisht
Pereira, Cristiano Goncalves
Deng, Wanleng
Lee, Ju-Seog
Nathanson, Katherine L.
Aldape, Kenneth D.
Prieto, Victor G.
Stuart, Darrin
Davies, Michael A.
CLINICAL CANCER RESEARCH, 2014, 20 (21) : 5537 - 5546
[9] Targeting the PI3K-Akt pathway in kidney cancer
Park, Jin-Young
Lin, Pei-Yin
Weiss, Robert H.
EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (06) : 863 - 870
[10] CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy
Marisol Salgado-Albarrán
Julian Späth
Rodrigo González-Barrios
Jan Baumbach
Ernesto Soto-Reyes
npj Systems Biology and Applications, 8

← 1 2 3 4 5 →